David
Jiménez Castro

2024

1. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

   Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 143-152

2. C-reactive Protein and Risk of Right Ventricular Dysfunction and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

   Archivos de Bronconeumologia, Vol. 60, Núm. 6, pp. 344-349

3. Chronic thromboembolic pulmonary hypertension treatment and sex: Systematic review and meta-analysis

   Medicina Clinica, Vol. 163, Núm. 6, pp. 269-274

4. Clinical Presentation and Outcomes of Patients with Cancer-Associated Isolated Distal Deep Vein Thrombosis

   Journal of Clinical Oncology, Vol. 42, Núm. 5, pp. 529-537

5. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

   Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 8, pp. 2234-2246

6. Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review

   Seminars in Thrombosis and Hemostasis, Vol. 50, Núm. 6, pp. 851-865

7. External validation of the PE-SARD risk score for predicting early bleeding in acute pulmonary embolism in the RIETE Registry

   Thrombosis Research, Vol. 235, pp. 22-31

8. Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications

   Seminars in Thrombosis and Hemostasis, Vol. 50, Núm. 5, pp. 773-789

9. High-Sensitivity vs Conventional Troponin Cutoffs for Risk Stratification in Patients with Acute Pulmonary Embolism

   JAMA Cardiology, Vol. 9, Núm. 1, pp. 64-70

10. Impact of a pulmonary embolism response team (PERT) in the prognosis of patients with acute symptomatic pulmonary embolism

    Revista Clinica Espanola, Vol. 224, Núm. 3, pp. 141-149

11. Incidence and predictors of post-thrombotic syndrome in patients with proximal DVT in a real-world setting: findings from the GARFIELD-VTE registry

    Journal of Thrombosis and Thrombolysis, Vol. 57, Núm. 2, pp. 312-321

12. Integration of Extracorporeal Membrane Oxygenation into the Management of High-Risk Pulmonary Embolism: An Overview of Current Evidence

    Hamostaseologie, Vol. 44, Núm. 3, pp. 182-192

13. Lung Cancer Related Thrombosis (LCART): Focus on Immune Checkpoint Blockade

    Cancers, Vol. 16, Núm. 2

14. Obesity a Prognostic Marker in Intermediate-high risk Pulmonary Embolism (PE)? RIETE Registry Review

    Thrombosis Update

15. Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease

    Nature Reviews Cardiology, Vol. 21, Núm. 8, pp. 574-592

16. Outpatient management of cancer-associated pulmonary embolism: A post-hoc analysis from the HOME-PE trial

    Thrombosis Research, Vol. 235, pp. 79-87

17. Oxygen Therapy in Patients With Intermediate-Risk Acute Pulmonary Embolism: A Randomized Trial

    Chest, Vol. 165, Núm. 3, pp. 673-681

18. Predictors of pulmonary embolism in chronic obstructive pulmonary diseases patients admitted for worsening respiratory symptoms: An individual participant data meta-analyses

    European Journal of Internal Medicine

19. Profilaxis de la enfermedad tromboembólica venosa en pacientes hospitalizados por patología médica desde los servicios de urgencias españoles: estudio PROTESU II

    Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 36, Núm. 4, pp. 271-280

20. Pulmonary embolism: Put the sPESI into practice

    European Journal of Internal Medicine